How will 2025 rise to the challenge of meeting the demand for personalized healthcare? A perspective on the transformative advancements of 2024—highlighting the impact of AI, robotics, and digital ...
Late-breaking research reveals there is no benefit from high-dose chemotherapy followed by autologous stem cell transplant (ASCT) for patients with mantle cell lymphoma (MCL) in remission following ...